61 Results for "

SNIPER

" in MedChemExpress (MCE) Product Catalog:
Products (61)

61 Results for "SNIPER" in MCE Product Catalog:

Cat. No.: HY-111875
CAS No.: 2095244-54-3
Purity:  99.68%
Research Areas:  

Cancer

SNIPER(BRD)-1 is a SNIPER degrader of BRD4, cIAP1 and XIAP. SNIPER(BRD)-1 has IC50 values of 6.8 nM, 17 nM and 49 nM for cIAP1, cIAP2 and XIAP, respectively. SNIPER(BRD)-1 can be used for cancer research .
Cat. No.: HY-111876
Purity:  99.51%
Target:  

SNIPERs

Research Areas:  

Cancer

SNIPER(TACC3)-1 targets the TACC3 protein for degradation via the ubiquitin-proteasome pathway based on IAP ligand. SNIPER(TACC3)-1 induces cancer cell death .
Cat. No.: HY-128808
CAS No.: 2095244-42-9
Purity:  99.07%
Synonyms: E3 ligase Ligand 12
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

cIAP1 ligand 1 is the LCL161 derivative based IAP ligand. cIAP1 ligand 1 can be connected to the ABL ligand for protein by a linker to form SNIPER. cIAP1 ligand 1 can be used in prostate cancer research .
Cat. No.: HY-111844
CAS No.: 1351169-27-1
Purity:  97.91%
PROTAC RAR degrader-1 (Compound 9) is a potent and selective RAR PROTAC Degrader consisting of apoptotic protein inhibitors (IAPs) ligands. IAPs-based degraders are also known as SNIPERs. PROTAC RAR Degrader-1 reduces RARα levels in HT1080 cells in a concentration-dependent manner but is blocked by the proteasome inhibitor MG132 (HY-13259). PROTAC RAR Degrader-1 can be used in the study of nuclear receptor-related diseases. (Pink: RAR ligand 1 (HY-111843); Black: Linker (HY-140189); Blue: IAPs Ligand (HY-B0134)) .
Cat. No.: HY-111877
Purity:  99.81%
Target:  

SNIPERs

Research Areas:  

Cancer

SNIPER(TACC3)-2 targets the TACC3 protein for degradation via the ubiquitin-proteasome pathway based on IAP ligand. SNIPER(TACC3)-2 induces cancer cell death .
Cat. No.: HY-111857
CAS No.: 2112837-79-1
Purity:  98.04%
Synonyms: BMS-354825 carbaldehyde; PROTAC ABL binding moiety 4
Research Areas:  

Cancer

Dasatinib carbaldehyde (BMS-354825 carbaldehyde), the Dasatinib (ABL inhibitor) based moiety, binds to IAP ligand via a linker to form SNIPER .
Cat. No.: HY-129619
CAS No.: 2222354-91-6
Research Areas:  

Cancer

SNIPER(ER)-87 consists of an inhibitor of apoptosis protein (IAP) ligand LCL161 derivative that is conjugated to the estrogen receptor α (ERα) ligand 4-hydroxytamoxifen by a PEG linker, and efficiently degrades the ERα protein (IC50=0.097 μM). SNIPER(ER)-87 preferentially recruits XIAP to ERα in the cells, and XIAP is the primary E3 ubiquitin ligase responsible for the SNIPER(ER)-87-induced ERα degradation .
Cat. No.: HY-145895
CAS No.: 2906151-68-4
Purity:  99.58%
Target:  

FGFR SNIPERs

Research Areas:  

Cancer

SNIPER(TACC3)-11 is a potent FGFR3-TACC3 degrader. SNIPER(TACC3)-11 reduces FGFR3-TACC3 protein levels and suppressed the growth of FGFR3-TACC3 positive cancer cells .
Cat. No.: HY-128809
CAS No.: 2357114-70-4
Synonyms: E3 ligase Ligand 11
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

cIAP1 ligand 2 is the LCL161 derivative based IAP ligand. cIAP1 ligand 2 can be connected to the ABL ligand for protein by a linker to form SNIPER.
Cat. No.: HY-111872
CAS No.: 3093563-31-3
Purity:  99.79%
Target:  

SNIPERs Bcr-Abl

Research Areas:  

Cancer

SNIPER(ABL)-020, conjugating Dasatinib (ABL inhibitor) to Bestatin (IAP ligand) with a linker, induces the reduction of BCR-ABL protein .
Cat. No.: HY-111860
Target:  

SNIPERs Bcr-Abl

Research Areas:  

Cancer

SNIPER(ABL)-013, conjugating GNF5 (ABL inhibitor) to Bestatin (IAP ligand) with a linker, induces the reduction of BCR-ABL protein with a DC50 of 20 μM .
Cat. No.: HY-111861
CAS No.: 2222355-77-1
Target:  

SNIPERs Bcr-Abl

Research Areas:  

Cancer

SNIPER(ABL)-024, conjugating GNF5 (ABL inhibitor) to LCL161 derivative (IAP ligand) with a linker, induces the reduction of BCR-ABL protein with a DC50 of 5μM .
Cat. No.: HY-128804
CAS No.: 51951-05-4
Synonyms: PROTAC Linker 8
Target:  

PROTAC Linkers

Research Areas:  

Cancer

PEG3-O-CH2COOH (PROTAC Linker 8) is a PEG-based PROTAC linker can be used in the synthesis of SNIPERs .
Cat. No.: HY-111848A
Purity:  99.26%
Research Areas:  

Cancer

PROTAC AR Degrader-4 comprises a IAP ligand binding group, a linker and an Androgen Receptor (AR) binding group. PROTAC AR Degrader-4 is an AR degrader. Degradation inducers based on cIAP1 are called specific and non-genetic IAP-dependent protein erasers (SNIPERs) .
Cat. No.: HY-111848
CAS No.: 1351169-31-7
Research Areas:  

Cancer

PROTAC AR Degrader-4 comprises a IAP ligand binding group, a linker and an Androgen Receptor (AR) binding group. PROTAC AR Degrader-4 is an AR degrader. Degradation inducers based on cIAP1 are called specific and non-genetic IAP-dependent protein erasers (SNIPERs) .
Cat. No.: HY-122825
CAS No.: 2241690-03-7
Research Areas:  

Cancer

SNIPER(ER)-110 consists of a IAP ligand and an estrogen ligand, connected by a linker. SNIPER(ER)-51 induces estrogen receptor (ER) protein degradation with DC50s of <3 nM and 7.7 nM after 4 h and 48 h, respectively .
Cat. No.: HY-111874
CAS No.: 2222354-29-0
Target:  

SNIPERs Bcr-Abl

Research Areas:  

Cancer

SNIPER(ABL)-039, conjugating Dasatinib (ABL inhibitor) to LCL161 derivative (IAP ligand) with a linker, induces the reduction of BCR-ABL protein with a DC50 of 10 nM. IC50s are 0.54 nM, 10 nM, 12 nM, and 50 nM for ABL, cIAP1, cIAP2, XIAP, respectively .
Cat. No.: HY-111850
CAS No.: 339186-54-8
Synonyms: PROTAC IAP binding moiety 1
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

Bestatin-amido-Me, the Bestatin-based IAP ligand, binds to ABL inhibitor via a linker to form SNIPER .
Cat. No.: HY-111849
CAS No.: 1436868-85-7
Synonyms: CGP-57148B carbaldehyde; STI571 carbaldehyde; PROTAC ABL binding moiety 1
Research Areas:  

Cancer

Imatinib carbaldehyde (CGP-57148B carbaldehyde), the Imatinib (ABL inhibitor) based moiety, binds to IAP ligand via a linker to form SNIPER .
Cat. No.: HY-131178
CAS No.: 1258391-29-5
Purity:  98.05%
HG-7-85-01-NH2 is the HG-7-85-01 (ABL inhibitor) based moiety, binds to IAP ligand via a linker to form SNIPER .